Brian Slomovitz and David M. Gershenson/LinkedIn
May 14, 2026, 17:13
Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary – IJGC
International Journal of Gynecological Cancer (IJGC), shared a post on LinkedIn:
”New IJGC Conversations episode!
Ribociclib+Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG3026 with Brian Slomovitz and David Gershenson
Tune in now.”
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 14, 2026, 17:11Christopher Robinson: Isolated Severe Systolic Hypertension During Delivery Admission and Maternal Outcomes
-
May 14, 2026, 17:08Ally Murji: Honoured to Deliver the 51st Annual RT Weaver Lecture at McMaster University
-
May 14, 2026, 17:00Your Hair Dye Could Be Affecting Your Fertility – Fertility Plus
-
May 14, 2026, 16:53Devora Lieberman on Reduced-Tip Needle Design and Its Role in Egg Collection for Older Women – City Fertility
-
May 14, 2026, 16:48AI Can Watch Your IVF Embryo Grow and Predict If It’s Chromosomally Normal, Without Any Biopsy – Fertility Plus
-
May 14, 2026, 12:04Asma Khalil: Why Twin Pregnancies Need More Than Routine Monitoring?
-
May 14, 2026, 12:01Marco Zaccaria: Why Distension Media Selection Matters in Modern Hysteroscopy
-
May 14, 2026, 11:58Mathew Leonardi: PCOS Has Been Renamed to PMOS and It Changes How We Understand the Disease
-
May 14, 2026, 10:41Nitin Kataria: Should Every IVF Lab Track KPI Trends Publicly?